Send us a text

This conversation starts with Stephen Harrison discussing the scope of current NITs in the context of what NAIL-NIT needs to achieve. "We don't need to reinvent the wheel, " he says, "only to make it run smoother." After Naim Alkhouri and Mazen Noureddin discuss the Phase I facilities they are building for future research, the group closes the conversation by focusing on the medical, commercial, financial and patient-centric imperatives that make it so imperative to develop appropriate NIT-based solutions for drug development, diagnosisis and patient management within the next five years.

This week marks the 2nd anniversary of Surfing the NASH Tsunami! Thank you for being part of the process that has brought us this far: 126 episodes and 335 separate podcast postings and over 58,000 downloads by individuals in over 105 different countries! We promise you this: the best of NASH Tsunami lies ahead of us.